Pharmaceutical compositions comprising a soluble laminin receptor precursor or a compound which blocks the interaction of the laminin receptor precursor and PrPSc or PrPc

摘要

The present invention relates to pharmaceutical compositions comprising a soluble laminin receptor precursor (LRP) or a modification thereof. The present invention also relates to pharmaceutical compositions comprising a compound which blocks the interaction of LRP and PrPSc or PrPc. Said compositions allow the treatment of diseases associated with the presence of PrPSc. In addition, the present invention provides an expression vector for the recombinant production of LRP or any other kind of protein in the baculovirus system.